About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

AstraZeneca's "Smoke and Mirrors" Man Has New Job in Medical Writing

By Jim Edwards | Apr 6, 2009

Whatever happened to AstraZeneca’s “smoke and mirrors” man, Richard Lawrence? You remember him. He was the one who, in 1997, wrote a memo about Seroquel that praised the company’s efforts to put a “positive spin” on “this cursed study,” and added:

I am not 100% comfortable with this data being made publically available at the present time … however I understand we have little choice … Lisa has done a great ’smoke-and-mirrors’ job!

It later emerged that among Seroquel’s side effects were weight gain and diabetes.

Turns out Lawrence is still in the writing business. He’s now the president of Gardiner-Caldwell Communications. Among GGC’s services are “Medical Writing and Strategy,” including:

Proven excellence in writing items ranging from sales aids to manuscripts and from Web sites to monographs for the many different healthcare professional and patient audiences.

Good luck to him in his new career.

Separately, there’s an in-depth piece on how AstraZeneca promoted Seroquel in the St. Pete Times today.


Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.

BNET User Analysis

Web Buzz:
  • AstraZeneca's Fuzzy Seroquel Math: When 45% Gain Weight, It's "Weight-Neutral"

    BNET Pharma - 30 days 7 hours 57 minutes ago

    Even though AstraZeneca executives wrote emails in 1997 saying they believed Seroquel caused weight gain, AZ instructed product managers to promote

  • There is absolutely no truth in the rumor......

    PharmaGossip - 222 days 9 hours 53 minutes ago

    ...... that AstraZeneca are planning to launch a Seroquel and Onglyza combination product! Yet

  • E-Mail: AstraZeneca Knew in 1997 that Seroquel Caused Weight Gain

    BNET Pharma - 249 days 2 hours 13 minutes ago

    AstraZeneca knew as far back as 1997 that Seroquel put patients at risk of weight gain, according to the company's own internal memos. The documents also appear to show that some AZ execs developed strategies to "neutralize" information that suggested Seroquel caused weight gain or diabetes, even after the FDA asked the company to warn

  • AZ Seroquel Emails Detail Off-Label Promotion; What Did CEO Brennan Know?

    BNET Pharma - 171 days 8 hours 18 minutes ago

    A new batch of email and memos from the federal litigation over AstraZeneca’s antipsychotic Seroquel detail company executives discussing off-label promotion, the stretching of data to make claims that Seroquel did not cause weight gain, the cover-up of a trial that showed negative results and suggestions that researchers who “slow up” the...

  • AstraZeneca - Seroquel: call Dr John "Harry Potter" Patterson

    PharmaGossip - 31 days 10 hours 48 minutes ago

    AstraZeneca Plc advised its sales force to promote the antipsychotic drug Seroquel as “weight neutral” four years after company research found “clinically significant” weight gains in users, internal documents show. AstraZeneca’s “global strategy is to demonstrate to consumers that Seroquel has a weight-neutral profile,” Debbie...

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement